Details

Autor(en) / Beteiligte

• Huang, Kecheng
• Sun, Haiying
• Chen, Zhilan
• Li, Xiong
• Wang, ShaoShuai
• Zhao, Xiaolin
• Tang, Fangxu
• Jia, Yao
• Hu, Ting
• Du, Xiaofang
• Wang, Haoran
• Lu, Zhiyong
• Huang, Jia
• Gui, Juan
• Wang, Xiaoli
• Zhou, Shasha
• Wang, Lin
• Zhang, Jincheng
• Guo, Lili
• Yang, Ru
• Shen, Jian
• Zhang, Qinghua
• Li, Shuang
• Wang, Shixuan

Titel

Optimal pathological response indicated better long-term outcome among patients with stage IB2 to IIB cervical cancer submitted to neoadjuvant chemotherapy

Ist Teil von

• Scientific reports, 2016-06, Vol.6 (1), p.28278-28278, Article 28278

Ort / Verlag

England: Nature Publishing Group

Erscheinungsjahr

2016

Quelle

Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals

Beschreibungen/Notizen

• The role of pathological response in long-term outcome is still unclear in cervical cancer patients treated with neoadjuvant chemotherapy (NACT) in China. This study aimed to investigate the effect of optimal pathologic response (OPR) on survival in the patients treated with NACT and radical hysterectomy. First, 853 patients with stage IB2-IIB cervical cancer were included in a retrospective analysis; a Cox proportional hazards model was used to investigate the relationship between pathological response and disease-free survival (DFS). In the retrospective database, 64 (7.5%) patients were found to have achieved an OPR (residual disease <3 mm stromal invasion); in the multivariate Cox model, the risk of death was much greater in the non-OPR group than in the OPR group (HR, 2.61; 95%CI, 1.06 to 6.45; P = 0.037). Next, the role of OPR was also evaluated in a prospective cohort of 603 patients with cervical cancer. In the prospective cohort, 56 (9.3%) patients were found to have achieved an OPR; the log-rank tests showed that the risk of recurrence was higher in the non-OPR patients than in the OPR group (P = 0.05). After combined analysis, OPR in cervical cancer was found to be an independent prognostic factor for DFS.